Enhancing Fairness in AI/ML Models for Healthcare Using Real-World Data

By Charmi Patel

May 22, 2024

Introduction

The latest research in artificial intelligence (AI) and machine learning (ML) has completely transformed healthcare industry, providing solutions for risk prediction, disease diagnosis, and outcome forecasting. The integration of AI/ML with real-world data (RWD) has shown promise in improving healthcare decision-making processes. However, concerns about algorithmic bias and fairness have emerged, emphasising the need for comprehensive research in this area.

Understanding Algorithmic Bias in Healthcare

Algorithmic fairness in AI/ML applications is crucial to prevent biases that could disproportionately impact different societal groups. Furthermore, examples from healthcare, such as biassed health cost predictions and disparities in disease outcomes, underscore the importance of fair AI/ML practices in healthcare settings.

Assessing Fairness in AI/ML Models

Researchers use metrics such as equality of opportunity, predictive parity, and statistical parity to assess fairness in ML models. Subsequently, they commonly apply pre-processing techniques like reweighing and data imputation to mitigate bias and improve fairness in healthcare applications.

Mitigating Bias in Healthcare AI/ML

Studies have explored pre-processing, in-processing, and post-processing methods to address bias in ML models. Furthermore, techniques such as recalibration and reweighing have shown promise in improving fairness and reducing disparities in healthcare predictions.

Future Research and Recommendations

Future research should focus on expanding fair ML practices into multi-modality and unstructured data. Consequently, this enhances model interpretability, addressing biases in data collection and governance. Collaborative efforts among AI experts, healthcare professionals, and ethicists are essential to ensure the ethical and equitable use of AI/ML in healthcare settings.

Advancing fair AI/ML practices in healthcare with RWD highlights the need for ongoing research. This promotes trustworthy and inclusive healthcare decision-making processes. Continuous exploration in this field is crucial. Lastly, it highlights the critical nature of ongoing investigations in advancing healthcare AI/ML practices.

The Role of Explainable AI in Healthcare

Explainable AI plays a vital role in healthcare by providing transparency and interpretability in AI/ML models, aiding in understanding how decisions are made and increasing trust in the technology.

Reference url

Recent Posts

biosimilars price competition
      

The Impact of MFN Pricing on the U.S. Biosimilar Market

💊 Could MFN Pricing Undermine Biosimilars?

MFN drug pricing aims to cut costs—but its indirect pressure on biosimilars may reduce competition (create a void) and raise long-term prices.

Explore the risks and what stakeholders can do to protect market sustainability.

#SyenzaNews #Biosimilars #DrugPricing #HealthPolicy #Pharma #MarketAccess

EU AI Act Healthcare Compliance
     

Navigating EU AI Act Healthcare Compliance: Proactive Steps for Ethical AI Integration

🔍 Are you prepared for the upcoming EU AI Act in healthcare?

As the first comprehensive AI regulation globally rolls out, healthcare organizations must move beyond mere compliance. The urgency lies in embedding ethical, trusted, and sustainable AI practices into every facet of healthcare AI. Early adoption of ethical assessments and collaboration is essential to navigate the complex regulatory landscape before the August 2026 deadline.

Learn about proactive compliance strategies that not only meet regulatory standards but also enhance patient trust and system efficacy!

#SyenzaNews #AIinHealthcare #HealthcareInnovation #DigitalTransformation

hepatitis vaccine uptake
         

Hepatitis Vaccine Uptake: Trends, Challenges, and the Role of Pharmacists

💉 Are we doing enough to bridge the gap in hepatitis vaccine uptake?

A recent article highlights that while over 90% of children are vaccinated against hepatitis B, adult rates are alarmingly low, posing a significant public health risk. Jeff Goad from the National Foundation for Infectious Diseases emphasizes the crucial role pharmacists can play in increasing access and dispelling common misconceptions about vaccines.

Join the conversation on enhancing vaccination strategies for better health outcomes!

#SyenzaNews #Healthcare #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.